Anti-TNF-alpha Trough Level Measurements in Inflammatory Bowel Disease
Status:
Completed
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
Drug serum concentrations will be measured at several time-points for inflammatory disease
patients treated with anti-TNF agents. The purpose is to determine which patients that will
clinically benefit from either discontinue treatment, adjusting the dose, switch to another
anti-TNF agent or a different class of medication.